Groundbreaking Passive Immunisation Therapy Trial
Image Source: ARY News

The province of Sindh has reported its first-ever successful recovery of a COVID-19 patient using the passive immunization therapy method.

Dr. Tahir Shamsi, the head of the National Institute of Blood Disease & Bone Marrow Transplantation (NIBD & BMT) and hematologist shared:

“The first patient to recover from the coronavirus with the use of passive immunization therapy has been sent home,”

Passive Immunisation Therapy Trial
Image Source: SAMAA News

Dr. Shamsi shared that the patient was administered plasma on 30th April and had wholly recovered on 8th May. The second test for Coronavirus that was conducted on the patient came back negative.

Reportedly, over 12 patients are currently being treated using passive immunization therapy, according to the doctor.

The Sindh government had earlier approved the passive immunization therapy process for patients towards the end of March to treat patients across the province.

This entire process has been operating under the supervision of Dr. Shamsi. The plasma technique may very well be applicable for other provinces as a part of a detailed strategy and plan to combat the novel coronavirus pandemic in hospitals across Pakistan.

According to the doctor:

“Under this technique, blood plasma from a healthy person is extracted and injected into the blood of a patient suffering from the Coronavirus.

After the transfer, the injected plasma generates anti-bodies in the immune system of the patient suffering from the Coronavirus. These anti-bodies eventually fight off the virus,”

What is Passive Immunisation Therapy?


Health experts say that this therapy is used to treat the high-risk infection with minimal time for the human body to recover by using its immune response system, or the ability to reduce the symptoms of the ongoing disease.

No vaccine has yet been approved by the authorities and has been recognized as the COVID-19 cure. Several countries are already working towards the treatment with scientists and researchers working around the clock along the medical frontline.